Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sana Biotechnology, Inc.

5.63
+0.06501.17%
Volume:2.04M
Turnover:11.32M
Market Cap:1.45B
PE:-5.29
High:5.67
Open:5.55
Low:5.39
Close:5.56
52wk High:7.30
52wk Low:1.26
Shares:257.00M
Float Shares:166.00M
Volume Ratio:0.62
T/O Rate:1.23%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0643
EPS(LYR):-1.1553
ROE:-109.12%
ROA:-26.30%
PB:11.80
PE(LYR):-4.87

Loading ...

Sana Biotechnology Q2 Adjusted EPS USD -0.16 VS. Ibes Estimate USD -0.21

THOMSON REUTERS
·
Aug 12

Sana Biotechnology Reports Second Quarter 2025 Financial Results and Business Updates

GlobeNewswire
·
Aug 12

Sana Biotechnology Inc. Files Prospectus for Public Offering, Aiming to Raise $75 Million in Gross Proceeds

Reuters
·
Aug 08

Top Midday Decliners

MT Newswires Live
·
Aug 08

Dow Dips Over 300 Points; US Initial Claims Rise

Benzinga
·
Aug 08

BUZZ-U.S. STOCKS ON THE MOVE-Sempra, Occidental Petroleum, APA

Reuters
·
Aug 08

BUZZ-U.S. STOCKS ON THE MOVE-Viatris, Ralph Lauren, Kontoor Brands

Reuters
·
Aug 07

Sana Biotechnology Inc - Prices Public Offering at $3.35 per Share

THOMSON REUTERS
·
Aug 07

Sana Biotechnology Inc. Announces $75 Million Public Offering of Common Stock and Pre-Funded Warrants

Reuters
·
Aug 07

BRIEF-Seres Therapeutics QTRLY Loss Per Share $2.27

Reuters
·
Aug 06

Seres Therapeutics Inc: Qtrly Loss per Share $2.27

THOMSON REUTERS
·
Aug 06

Seres Therapeutics: Continues to Evaluate Cost Reduction Actions Aimed at Extending Cash Runway

THOMSON REUTERS
·
Aug 06

Seres Therapeutics Inc: Expects to Fund Operations Into Q1 2026

THOMSON REUTERS
·
Aug 06

Sana Biotechnology Inc expected to post a loss of 21 cents a share - Earnings Preview

Reuters
·
Aug 04

Sana Biotechnology Coverage Assumed by Morgan Stanley at Overweight

Dow Jones
·
Jul 04

Sana Biotechnology Shares Climb on Positive Diabetes Study Results

Dow Jones
·
Jun 23

BRIEF-Sana Biotechnology Says Six-Month Results Show Islet Cells Safe & Functional

Reuters
·
Jun 23

Sana Biotechnology Inc. Files Initial Statement of Beneficial Ownership for Director Robert L. Rosiello

Reuters
·
Jun 10

Sana Biotechnology Announces Six-Month Clinical Results of Hypoimmune Pancreatic Islet Cell Therapy at ADA Scientific Sessions

Reuters
·
Jun 10

Sana Biotechnology Inc. Concluded Annual Stockholders Meeting

Reuters
·
Jun 07